Literature DB >> 3906350

Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus.

P J Campbell, G B Bolli, P E Cryer, J E Gerich.   

Abstract

During constant insulin infusion (0.15 mU X kg-1 X min-1) from 12 PM to 8 AM in 10 IDDM patients previously rendered euglycemic (Biostator), plasma glucose (5.4 +/- 0.2 mmol/L at 12 PM) increased by 3:30 AM and reached 12.1 +/- 1.6 mmol/L at 8 AM (P less than 0.001). Glucose production also increased at 3:30 AM; hyperglycemia, glucose utilization did not increase until after 5 AM. Plasma growth hormone (12 PM to 4 AM), cortisol (after 3:30 AM), noradrenaline (after 1:30 AM), and adrenaline (after 3:30 AM) but not glucagon increased significantly overnight, although plasma adrenaline and noradrenaline remained at subthreshold levels. Insulin clearance increased (approximately 25%, P less than 0.05) but only after 7 AM, resulting in a 4 mU/L decrease in plasma insulin. A significant correlation was found between increases in plasma glucose and increases in glucose production (r = 0.74, P less than 0.05) which in turn were significantly correlated with nocturnal peaks in plasma growth hormone (r = 0.66, P less than 0.05). From the sequence of events observed, we conclude that the Dawn Phenomenon in IDDM begins earlier than is currently thought (approximately 3:30 AM), that it is due to both accelerated glucose production and impaired glucose utilization, and that nocturnal increases in sympathetic nervous system activity and/or growth hormone secretion, but not changes in secretion of cortisol, adrenaline and glucagon or changes in insulin clearance, may be of pathogenetic importance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906350     DOI: 10.1016/0026-0495(85)90153-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

2.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

Review 4.  Circadian clock control of endocrine factors.

Authors:  Karen L Gamble; Ryan Berry; Stuart J Frank; Martin E Young
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

5.  Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.

Authors:  B Beaufrère; M Beylot; C Metz; A Ruitton; R François; J P Riou; R Mornex
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

6.  Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.

Authors:  B R Pal; P E Phillips; D R Matthews; D B Dunger
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

7.  Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity.

Authors:  Jane E Yardley
Journal:  Diabetologia       Date:  2022-08-18       Impact factor: 10.460

8.  Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

Authors:  S Dinneen; A Alzaid; J Miles; R Rizza
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Different effects of octreotide by continuous night infusion at increasing rate or by evening injections at different times on morning hyperglycemia and growth hormone levels in insulin-dependent diabetic patients.

Authors:  M Lunetta; M Di Mauro; R Le Moli
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

10.  REM sleep latency as an independent risk for cardiovascular events in hemodialysis patients.

Authors:  Shigeichi Shoji; Masaaki Inaba; Koichiro Yoda; Hisanori Okazaki; Mio Toyokawa; Kyoko Norimine; Tomoyuki Yamakawa; Senji Okuno
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.